GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Incyte Corporation
Incyte Corporation
Massachusetts General Hospital
Tr1X, Inc.
Melbourne Health
University of Kansas Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Gilead Sciences
M.D. Anderson Cancer Center
University College, London
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Dana-Farber Cancer Institute
University of Chicago
Northwestern University
Northwestern University
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)